🧬 Performance Peptides

What Are Performance Peptides?

Performance peptides are short chains of amino acids used to enhance athletic recovery, muscle growth, endurance, and body composition[citation:2]. They function as signaling molecules that direct cells to repair, regenerate, or regulate specific systems[citation:9].

However, the term “performance peptides” covers two very different categories:

Oral Supplement Peptides: PeptiStrong™

In October 2024, Designs for Health launched Performance Peptides™, a supplement featuring PeptiStrong™—a plant-based bioactive peptide derived from the fava bean (Vicia faba)[citation:1][citation:5].

Key features:

• AI‑discovered: The peptides were identified using an AI platform that matched bioactive sequences to biochemical pathways[citation:1].
• Human evidence: A 14‑day placebo‑controlled study in 30 healthy men showed improved recovery and reduced fatigue after resistance training[citation:8].
• Purpose: Supports muscle strength, endurance, retention, and healthy body composition, especially in aging adults or those on GLP‑1 weight‑loss plans[citation:5].
• Mechanism: Acts on pathways that stimulate muscle protein synthesis[citation:8].

The product is positioned as a dietary supplement, not a drug, and makes structure‑function claims rather than disease‑treatment claims[citation:8].

Injectable Research Peptides

The injectable category is where performance peptides become controversial. These compounds are largely unregulated, sold online as “research chemicals,” and used off‑label by athletes and biohackers[citation:6][citation:9].

A 2026 review in the Journal of Sports Medicine and Physical Fitness noted that peptides have “become attractive in both medical research and bodybuilding communities” due to their enhanced stability and receptor selectivity[citation:6]. However, the authors emphasized that “the clinical evidence supporting peptide use in sport is limited” and that most studies examine therapeutic applications—not the supraphysiological or combined protocols common in performance settings[citation:6].

Popular Injectable Peptides & Their Claims

The table below is adapted from a 2026 Frontiers in Endocrinology review of peptides modulating the GH‑IGF‑1 axis[citation:4].

A 2026 narrative review in Frontiers in Endocrinology categorized these compounds into evidence tiers, with most falling into Tier B–D (Phase 1 data, preclinical, or no human studies) rather than Tier A (regulatory‑grade randomized trial data)[citation:4].

The Evidence Gap: What We Don’t Know

A 2026 review in the American Journal of Sports Medicine evaluated the evidence for injectable peptides in orthopaedic and sports medicine[citation:3]. Key findings:

• BPC‑157: Animal studies show potential for tendon and muscle repair, but findings are “largely unvalidated in human trials.” A single human case series reported pain improvement after knee injections, but had significant methodological flaws[citation:3].
• TB‑500: Promoted angiogenesis and tissue repair in preclinical models, but “human orthopaedic data are lacking.” Both BPC‑157 and TB‑500 are banned substances in sport[citation:3].
• CJC‑1295 + ipamorelin: Murine models showed improved muscle tension, but these findings are limited to animal studies[citation:3].
• Tesamorelin: Approved for HIV‑associated lipodystrophy, but “no supporting orthopaedic evidence” exists[citation:3].
• GHK‑Cu: Showed wound‑healing and anti‑inflammatory effects in vitro, but “no clinical data support its use for musculoskeletal conditions”[citation:3].

The authors concluded: “While peptide therapy may possess significant therapeutic and regenerative potential, it is critical that orthopaedic and sports medicine providers understand the current lack of evidence to support the clinical use of these peptides. Importantly, information regarding the indications, dosing, frequency, and duration of treatment remains unknown.”

Safety & Regulatory Status

⚠️ Key Safety Concerns

• Endocrine and metabolic disturbances: Including prolactin and cortisol elevations, appetite changes, and dysglycemia[citation:4].
• Fluid retention and musculoskeletal symptoms: Myalgia, arthralgia, and injection‑site reactions[citation:4].
• Mitogenic concern: Chronic GH/IGF‑1 elevation is a theoretical cancer risk—though no established clinical carcinogenic signal has been confirmed[citation:4].
• Cardiovascular strain, insulin resistance, and psychiatric instability: Emerging data highlight these potential risks[citation:6].
• Product quality: The largely unregulated supply chain means products are often mislabeled or contaminated[citation:6].

📋 Regulatory Status

• WADA banned: Most performance peptides are prohibited in‑ and out‑of‑competition by the World Anti‑Doping Agency[citation:6].
• No FDA approval: None of the injectable performance peptides are FDA‑approved for muscle growth, recovery, or performance enhancement[citation:9].
• Gray‑market reality: Often sold online as “research chemicals” with uncertain purity, dose consistency, and sterility[citation:4][citation:9].
• Legitimate clinics: Some concierge clinics offer peptides under medical supervision, but even these uses are off‑label and lack robust evidence[citation:9].

Performance peptides represent a spectrum: from AI‑discovered plant‑based supplements with small human trials, to injectable research compounds with preclinical promise and significant unknowns. The oral supplement category—exemplified by PeptiStrong™—offers a safer, evidence‑based option for muscle support and recovery. The injectable category, however, remains experimental, unregulated, and associated with real risks. For most people, the foundation of performance—nutrition, sleep, exercise, and stress management—remains more powerful and better proven than any peptide[citation:2]. If you are considering peptide therapy, consult a physician experienced in peptide pharmacology, and never buy from unregulated online sources.

❓ FAQs About Performance Peptides

✧ Written in service of evidence‑based performance and patient safety ✧